Kim Robien

Tabs

Bio

Dr. Robien is a cancer epidemiologist and nutrition scientist. She is also a Registered Dietitian and a Certified Specialist in Oncology Nutrition (CSO), and practiced as an oncology dietitian for more than 10 years prior to beginning her research career.

Dr. Robien's group is currently studying the extent to which dietary exposure to endocrine disrupting chemicals (especially bisphenols and phthalates) is associated with doxorubicin resistance among women with triple negative breast cancer, as well as the effect of body composition (lean body mass vs. adipose tissue) on chemotherapy toxicity and treatment completion rates among patients undergoing treatment for breast cancer. In addition to her clinical oncology research, Dr. Robien has extensive experience with large prospective cohort studies of diet and cancer prevention as an investigator and PI with the Iowa Women's Health Study.

Dr. Robien received her PhD in Nutritional Sciences from the University of Washington, and completed a postdoctoral fellowship in molecular epidemiology at the Fred Hutchinson Cancer Research Center in Seattle. Prior to joining the GW faculty in 2012, Dr. Robien was a member of the faculty of the University of Minnesota’s School of Public Health, where she was an active member of the University of Minnesota Masonic Cancer Center.

Dr. Robien has authored more than 130 peer-reviewed research publications, and serves on the Editorial Board for Nutrition in Clinical Practice. She is also a member of the GW Cancer Center, and a fellow with the Sumner M. Redstone Global Center for Prevention and Wellness.

Expertise

Expertise:

Nutrition

Chronic Disease

Obesity

Aging

Food and Drug Safety

Environmental and Occupational Health

Epidemiology

Cancer Policy

Education:

Bachelor of Science, Dietetics, University of Wisconsin, Madison, 1989

Masters of Science, Dietetics, Massachusetts General Hospital Institute of Health Professions, 1991

Doctorate, Nutritional Sciences, University of Washington, Seattle, 2003

Teaching:

PUBH 6612, Food Systems in Public Health

PUBH 6620, Designing Healthy Communities

EXNS 2122, Food Systems in Public Health

Community Service:

Editorial Board, Nutrition in Clinical Practice

Ad hoc grant reviewer for National Institutes of Health, National Institute for Health Research and Policy Research Programme (UK), Canadian Cancer Society, American Institute for Cancer Research

Member, Academy of Nutrition and Dietetics

Member, Society for Epidemiologic Research (SER)

Member, American Society of Preventive Oncology (ASPO)

Member, American Association for Cancer Research (AACR)

Member, American Society for Clinical Oncology (ASCO)

Member, Multinational Association for Supportive Cancer in Cancer (MASCC)

Member, American Medical Informatics Association (AMIA)

Member, Cancer Informatics for Cancer Centers (Ci4CC)

Member, Observational Health Data Sciences and Informatics (OHDSI)

Institutes and Centers:

GW Cancer Center

Sumner M. Redstone Global Center for Prevention and Wellness

Research

Research:

The two overarching goals of Dr. Robien's research are to: 1) better understand how changes in diet and body composition could be used to minimize treatment-related toxicity and maximize effectiveness of existing cancer treatment regimens, and 2) identify and eliminate sources of disparities in cancer treatment outcomes. Dr. Robien's previous research has found that dietary and supplemental folate intake during anti-folate chemotherapy (methotrexate, 5-FU) is not associated with adverse outcomes among patients being treated with blood and marrow transplantation for chronic myelogenous leukemia, although treatment outcomes did vary by methylenetetrahydrofolate reductase (MTHFR) genotype. Her group has also reported that vitamin D supplementation did not improve musculoskeletal symptoms related to aromatase inhibitor treatment among women being treated for breast cancer. Dr. Robien's group is currently studying the extent to which dietary exposure to endocrine disrupting chemicals (especially bisphenols and phthalates) is associated with doxorubicin resistance among women with triple negative breast cancer, as well as the effect of body composition (lean body mass vs. adipose tissue) on chemotherapy toxicity and treatment completion rates among patients undergoing treatment for breast cancer.

In addition to her clinical oncology research, Dr. Robien has extensive experience working with cancer epidemiology cohorts and pooled data analysis projects. She is an investigator with the Iowa Women's Health Study, a prospective longitudinal cohort study of 40,000 Iowa women who were post-menopausal at the initiation of the study in 1986. The primary aims of the study are to investigate the association of dietary and other lifestyle factors with risk for cancer . She has also served as a member of the National Cancer Institute’s (NCI) Cohort Consortium and as a collaborator in the Pooling Project of Prospective Studies of Diet and Cancer since 2010.

Publications

Publications:

Selected recent publications - View Dr. Robien's full publication list

Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, Patel AV, Andrews KS, Bandera EV, Spees CK, Robien K, Hartman S, Sullivan K, Grant BL, Hamilton KK, Kushi LH, Caan BJ, Kibbe D, Black JD, Wiedt TL, McMahon C, Sloan K, Doyle C. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin 2020;70(4):245-271. PMID: 32515498.

Onyeaghala G, Lintelmann AK, Joshu CE, Lutsey PL, Folsom AR, Robien K, Platz EA, Prizment AE. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention guidelines and colorectal cancer incidence among African Americans and whites: The Atherosclerosis Risk in Communities study. Cancer 2020;126(5):1041-1050. PMID: 31873947.

Teras LR, Patel AV, Wang M, Yaun SS, Anderson K, Brathwaite R, Caan BJ, Chen Y, Connor AE, Eliassen AH, Gapstur SM, Gaudet MM, Genkinger JM, Giles GG, Lee IM, Milne RL, Robien K, Sawada N, Sesso HD, Stampfer MJ, Tamimi RM, Thomson CA, Tsugane S, Visvanathan K, Willett WC, Zeleniuch-Jacquotte A, Smith-Warner SA. Sustained weight loss and risk of breast cancer in women 50 years and older: A pooled analysis of prospective data. J Natl Cancer Inst 2020;112(9):929-937. PMID: 31845728.

Sweeney MR, Applebaum KM, Arem H, Braffett BH, Poynter JN, Robien K. Medical conditions and modifiable risk factors for myelodysplastic syndrome: A systematic review. Cancer Epidemiol Biomarkers Prev 2019;28(9):1502-1517. PMID: 31213463.

Blair CK, Jacobs DR Jr, Demark-Wahnefried W, Cohen HJ, Morey MC, Robien K, Lazovich D. Effects of cancer history on functional age and mortality. Cancer 2019;125(23):4303-4309. PMID: 31418826.

Merrigan K, Griffin T, Robien K, Wilde P, Dietz W, Goldberg J. Designing a sustainable diet. Science 2015; 350(6257):165-166. PMID: 26429883

Nomura SO, Harnack L, Robien K. Estimating BPA exposure levels using a questionnaire targeting known sources of exposure. Public Health Nutrition 2016;19(4):593-606. PMID: 26136114

Blair CK, Robien K, Inoue-Choi M, Rahn W, Lazovich D. Physical inactivity and risk of poor quality of life among elderly cancer survivors compared to women without cancer: The Iowa Women’s Health Study. Journal of Cancer Survivorship 2016;10(1):103-12. PMID: 26008207

Inoue-Choi M, Jones RR, Anderson KE, Cantor KP, Cerhan JR, Krasner S, Robien K, Weyer PJ, Ward MH. Nitrate and nitrite ingestion and risk of ovarian cancer among postmenopausal women in Iowa. Int J Cancer. 2015;137(1):173-82. PMID: 25430487

Oppeneer SJ, Robien K. Bisphenol A exposure and associations with obesity among adults: a critical review. Public Health Nutrition 2015;18(10):1847-63. PMID: 25311796

Inoue-Choi M, Robien K, Lazovich D. Adherence to the WCRF/AICR guidelines for cancer prevention is associated with lower mortality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev 2013;22(5):792-802. PMID: 23462914

Inoue-Choi M, Oppeneer SJ, Robien K. Reality check: there is no such thing as a miracle food. Nutr Cancer 2013;65(2):165-8. PMID: 23441603

Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract 2013 Apr;28(2):194-208. PMID: 23307906

Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, Oeffinger KC. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 2013;24(2):313-21. PMID: 23187859

Web 2019 Update - CSS

Kim

Robien, PhD, RD, CSO, FAND

Associate Professor

Kim Robien

Tabs